Clinical Trial

Clinical Safety Evaluation and Preliminary Efficacy Study of Subcutaneous Myografts Transplantation

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study aims to apply autologous differentiated myocyte subcutaneous transplantation in patients with muscle atrophy to explore its safety, feasibility, and efficacy.
Trial Details
NCT Number NCT07426068
Lead Sponsor National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China
Collaborators: National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation-Chinese PLA General Hospital, National Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation-Binhai Yangshi Orthopedic Hospital
Conditions Metabolic Disease, Amyotrophy
Enrollment 6 participants
Start Date 2026-07-01
Primary Completion 2028-02-01 (estimated)
Study Completion 2028-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-23